Baker Tilly’s life sciences practice helps clients navigate the increasingly complex patchwork of state and local drug pricing laws through our pricing strategy, price reporting and transparency services.

    Price transparency laws

    Some of the most common requirements of price transparency laws include:

    • Notice to payers and other stakeholders prior to introduction of a new product with a WAC above a specific amount
    • Providing commercial details  to regulators for new products with a WAC price that exceeds a specific threshold
    • Reporting detailed information to the state if the WAC price of a product is raised above a specific amount within a certain time period (e.g. 16% or more within two years)
    State price transparency reporting for life sciences companies
    Whitepaper

    State price transparency reporting for life sciences companies

    To help life sciences companies understand and comply with the myriad of ever-changing state drug price transparency reporting requirements, our team of Value Architects™ has put together an informative whitepaper to help alleviate the fear, uncertainty and doubt associated with navigating these regulations.

    State Drug Price Transparency Reporting for Life Sciences Companies
    Webinar

    State drug price transparency reporting for emerging life sciences companies

    Drug prices within the U.S. continue to be a point of discussion with consumers, lawmakers and professionals throughout the healthcare industry. Listen to our informative, on-demand presentation about state drug price transparency reporting requirements for life sciences companies that are about to launch their first product.